Vigabatrin for the Treatment of Cocaine Dependency

NCT01281202 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

207

Enrollment

INDUSTRY

Sponsor class

Conditions

Cocaine Addiction
Cocaine Dependence

Interventions

DRUG: Vigabatrin
DRUG: Matching Placebo

Sponsor

Catalyst Pharmaceuticals, Inc.

Collaborators

[object Object]
[object Object]